What is Diasol?
Diasol, Inc. operates as a specialized manufacturer of hemodialysis concentrates, playing a vital role in the renal care supply chain. The company maintains a sophisticated logistics network, anchored by manufacturing facilities in Phoenix, Arizona, and Watertown, Tennessee. This infrastructure is further bolstered by a strategic distribution presence in California and Texas, allowing for the precise delivery of electrolyte concentrations tailored to individual patient dialysis bath prescriptions. By focusing on high-quality, customizable medical inputs, Diasol has established itself as an essential partner for clinical facilities aiming to optimize patient outcomes through reliable and efficient supply chain management.
How much funding has Diasol raised?
Diasol has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Diasol
PPP
Public-Private Partnership
What's next for Diasol?
With the recent infusion of capital, Diasol is positioned to scale its manufacturing capabilities and further optimize its distribution network. The company's late-stage lifecycle status suggests a focus on operational efficiency and market penetration, likely targeting expanded capacity to meet the growing demand for specialized renal care products. Future strategic initiatives will likely involve enhancing production throughput at its existing sites and potentially exploring new regional distribution hubs to minimize lead times. As the healthcare landscape continues to prioritize patient-centric care, Diasol's ability to provide customized electrolyte solutions will remain a key competitive advantage, driving long-term value for both the company and the clinical providers it serves.
See full Diasol company page
